Danaos Corporation vs Inovio Pharmaceuticals Inc — how do they compare? Danaos Corporation trades at $135.01 (market cap $2.46B), while Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M). The key difference: Danaos Corporation is far larger — about 31.3× Inovio Pharmaceuticals Inc's market cap, and Danaos Corporation pays a 2.67% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| DAC | INO | |
|---|---|---|
Market Cap | $2.46B | $78.55M |
Sector | Technology | Health |
52-Week High | $143.15 | $2.87 |
52-Week Low | $84.05 | $0.66 |
Enterprise Value | $2.44B | $49.56M |
Dividend Yield | 2.67% | — |
Trailing returns across standard periods
Danaos is a leading international owner of containerships, providing seaborne transportation services globally. It charters its fleet of vessels to major shipping lines across Asia, Europe, and the Americas.
Read more on DAC →Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →